Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Trial to Evaluate the Efficacy, Safety and Tolerability of ARGX-113 in Patients with Myasthenia Gravis Having Generalized Muscle Weakness

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date06/12/19 → 06/12/21

Funding

  • Syneos Health LLC: $17,955.00